App-Quantinova.ai

SAT-599 Propylthiouracil-Induced Anaphylaxis with Subsequent Tolerance of Methimazole

Angela Liu - Endocrine Society (ENDO) , 2019

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Beta-thalassemia

Propylthiouracil

SAT-576 Lyme Disease Associated Thyroiditis

Navreet Deol - Endocrine Society (ENDO) , 2019

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Autoimmune Thyroid Disease

Sodium Iodide

SAT-546 Discovering the Function of IGSF1 and Its Role in the Hypothalamic-Pituitary-Thyroid Axis

Courtney Smith - Endocrine Society (ENDO) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Liver cancer

hGH

SUN-014 Identification of a New SUMOylation Process Regulating Nuclear Receptor Nor-1

Jonathan Gagnon - Endocrine Society (ENDO) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

SUN-011 Identification Of Regulators Of Estrogenic Signalling In ER-positive Breast Cancer Cells By Whole Genome shRNA Screening

Justyna Kulpa - Endocrine Society (ENDO) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Breast cancer

Alora

OR11-2 A Lifestyle Program Targeting Women with Obesity and Infertility Improves Their Fertility: A Randomized Controlled Trial

Matea Belan - Endocrine Society (ENDO) , 2019

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Infertility

N/A

OR08-6 RGS2 Expression Attenuates Contractile Signaling in Myometrial Smooth Muscle In Vitro

Daniela Urrego, BHSc - Endocrine Society (ENDO) , 2019

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Spontaneous preterm delivery

Prostaglandin

OR25-4 Modulatory Effects of Estradiol on the Resting-State Functional Connectivity in Transwomen Following Gender Affirming Surgery

Maiko Schneider - Endocrine Society (ENDO) , 2019

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Anxiety

Alora

MON-LB042 Health-Related Quality of Life in Women with Polycystic Ovary Syndrome/Anovulatory Androgen Excess versus Local Population-Based Control Women (from the British Columbia Canadian Multicentre Osteoporosis Study [BC CaMos])

Bernice Liang, BA - Endocrine Society (ENDO) , 2019

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Polycystic Ovary Syndrome

Androgen Tear

MON-229 IRX3 and IRX5 Regulate Downstream Targets that Promote Ovarian Follicle Integrity in Mice

Anqi Fu - Endocrine Society (ENDO) , 2019

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Immunodeficiency, common variable, 10

N/A

MON-215 Comparison of Ultrasonographic and Biochemical Markers of Polycystic Ovarian Morphology Across the Phenotypic Spectrum of Polycystic Ovary Syndrome

Brittany Jarrett - Endocrine Society (ENDO) , 2019

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Polycystic Ovary Syndrome

Androgen Tear

MON-213 Evaluation of Type 2 Diabetes and Cardiovascular Disease Risk Factors in Reproductive-Age Women with Polycystic Ovary Syndrome (PCOS) Using the 2014 Androgen Excess and PCOS Society Criteria for the Polycystic Ovarian Morphology

Maryam Kazemi - Endocrine Society (ENDO) , 2019

Therapeutic Area

Disease

Drug/Treatment

Dermatology

Polycystic Ovary Syndrome

Androgen Tear

SUN-244 Birth and Perinatal Characteristics of Children with Congenital GH Deficiency (GHD) Due to Abnormal Pituitary Development: Data from a Prospective, Multinational Observational Study

Christopher Child - Endocrine Society (ENDO) , 2019

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Ectopic Posterior Pituitary

N/A

SUN-154 Identifying Type 1 Diabetes in Electronic Medical Records and Administrative Health Data in Ontario: A Validation Study

Alanna Weisman - Endocrine Society (ENDO) , 2019

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Diabetic ketoacidosis

Metformin Hydrochloride

SAT-183 Activating Transcription Factor 4 (ATF4) As A Possible Mediator Of Gluconeogenic And Lipogenic Actions Of Fat Mass And Obesity Associated (FTO) In Liver

Tooru Mizuno - Endocrine Society (ENDO) , 2019

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Fatty Liver Disease

N/A

SAT-123 Burden of Type 2 Diabetes Genetic Risk Alleles Differs Among Physiologic Subtypes of Gestational Diabetes Mellitus

Camille Powe - Endocrine Society (ENDO) , 2019

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Gestational Diabetes

N/A

SUN-077 In Utero Growth Restriction Induces an Early Metabolic Shift in Fetal Rat Heart

Loïze Maréchal - Endocrine Society (ENDO) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

Carnitine

SAT-063 Peripheral Aldosterone Values During Simultaneous Bilateral Adrenal Veins Sampling (AVS) to Predict the Source of Aldosterone Secretion in Primary Aldosteronism (PA)

Matthieu St-Jean - Endocrine Society (ENDO) , 2019

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Primary aldosteronism

N/A

Decreased Baseline Diaphragm Thickness Independently Predicts Increased Risk of Morbidity and Mortality in Mechanically Ventilated Patients

M. C. Sklar - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Acute respiratory failure

N/A

Derived Smooth Muscle Cells on Human Lung Progenitors Is Dependent on Expression of Translationally Controlled Tumour Protein

M. Ho - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Lymphangioleiomyomatosis

N/A

Filters

28841 Abstracts